Literature DB >> 7646527

Effects of vitamin A deficiency and retinoic acid treatment on expression of a phosphoenolpyruvate carboxykinase-bovine growth hormone gene in transgenic mice.

D J Shin1, A Tao, M M McGrane.   

Abstract

Vitamin A regulation of specific promoter domains of the phosphoenolpyruvate carboxykinase (PEPCK) gene was tested in a PEPCK/bovine growth hormone (bGH) transgenic mouse model. Vitamin A deficiency causes a significant decrease in hepatic bGH mRNA when expression is driven by either a 533-base-pair (bp) PEPCK promoter fragment (from position -460 to +73) or a 428-bp PEPCK promoter fragment (from position -355 to +73). Treatment of vitamin A deficient transgenic mice with all-trans retinoic acid (RA) increases bGH mRNA levels above those measured with the deficiency. Hepatic retinoic acid receptor (RAR)beta mRNA levels also change with vitamin A deficiency and supplementation, but not RAR alpha mRNA levels. These results indicate that all-trans RA plays a physiologic role in regulating expression of a gluconeogenic gene in liver.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7646527     DOI: 10.1006/bbrc.1995.2188

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Retinoids induced Pck1 expression and attenuated insulin-mediated suppression of its expression via activation of retinoic acid receptor in primary rat hepatocytes.

Authors:  Yan Zhang; Rui Li; Wei Chen; Yang Li; Guoxun Chen
Journal:  Mol Cell Biochem       Date:  2011-04-26       Impact factor: 3.396

2.  CCAAT-enhancer-binding protein alpha (C/EBP alpha) is required for the thyroid hormone but not the retinoic acid induction of phosphoenolpyruvate carboxykinase (PEPCK) gene transcription.

Authors:  E A Park; S Song; M Olive; W J Roesler
Journal:  Biochem J       Date:  1997-02-15       Impact factor: 3.857

Review 3.  Roles of Vitamin A Metabolism in the Development of Hepatic Insulin Resistance.

Authors:  Guoxun Chen
Journal:  ISRN Hepatol       Date:  2013-09-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.